Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning

Bone Marrow Transplant. 2022 Dec;57(12):1837-1838. doi: 10.1038/s41409-022-01819-y. Epub 2022 Sep 17.

Authors

Dimana Dimitrova¹, Jennifer A Kanakry²

Affiliations

¹ Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National lnstitutes of Health, Bethesda, MD, USA. dimana.dimitrova@nih.gov.
² Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National lnstitutes of Health, Bethesda, MD, USA.

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cyclophosphamide
Hematopoietic Stem Cell Transplantation*
Humans
Pentostatin*
Transplantation Conditioning
Vidarabine

Substances

fludarabine
Pentostatin
Vidarabine
Cyclophosphamide